Scott W. Canna & Fabrizio De Benedetti. (2024). The 4th NextGen therapies of SJIA and MAS, part 4: It is time for IL-18 based trials in systemic juvenile idiopathic arthritis? BMC.
Chicago Style (17th ed.) CitationScott W. Canna and Fabrizio De Benedetti. The 4th NextGen Therapies of SJIA and MAS, Part 4: It Is Time for IL-18 Based Trials in Systemic Juvenile Idiopathic Arthritis? BMC, 2024.
MLA (9th ed.) CitationScott W. Canna and Fabrizio De Benedetti. The 4th NextGen Therapies of SJIA and MAS, Part 4: It Is Time for IL-18 Based Trials in Systemic Juvenile Idiopathic Arthritis? BMC, 2024.
Warning: These citations may not always be 100% accurate.